Diabetes Mellitus Type 1 Perspective

 
 
  • DUPC 2018 Read clinically focused news coverage of key developments from DUPC 2018
  • SGLT2 Inhibitors in Type 1 Diabetes Are SGLT2 inhibitors safe and effective in patients with type 1 diabetes?
  • ENDO 2018 Read clinically focused news coverage of key developments from ENDO 2018.
  • Which CGM for Which Diabetes Patient?   Dr Peters clarifies the pros and cons of the Dexcom and FreeStyle Libre continuous glucose monitors for patients with diabetes.
  • New Diabetes Guidelines Fail to Guide   An effort to encourage individualized treatment choices may muddy the therapy waters, says Dr Peters.
  • Type 2 Diabetes in Kids: Don't Miss It   Dr Tyree Winters stresses the importance of identifying at-risk kids and screening often, as much as annually, to be sure that early-stage type 2 diabetes is not missed.
  • What Cardiologists Need to Know About New Diabetes Drugs   Drs O'Donoghue and McGuire discuss the data on the various SGLT2 inhibitors and GLP1 receptor agonists and when to consider prescribing them to your patients with diabetes.
  • AHATrials We Did, Trials We Should Do Dr Walton-Shirley reflects on some major studies presented at AHA 2017 and offers a further way to approach each one.
  • 'Now Is the Time to Learn' About CGM   The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.
  • The Lowdown on the Lower GI Tract --More From WCOG at ACG 2017   Dr David Johnson continues to provide his takeaways from this meeting. In part 2, study highlights from the biliary tract and pancreas to the small intestine and colon are covered.
  • Ultra-fast Insulins Curb Mealtime Spikes   Faster-acting insulins are especially beneficial for patients on continuous glucose monitors who are keeping track of glucose peaks and valleys.
  • Dapagliflozin: 'Helpful Strategy' for T1D?   Research presented at EASD 2017 shows that dapagliflozin may reduce insulin requirements with a low risk of adverse effects in patients with type 1 diabetes.
  • Diabetes Mellitus Overview Video   This video provides an overview of diabetes mellitus, including type 1, type 2, gestational diabetes, and drug-induced diabetes.
  • The Data Show What I Expected... In the absence of definitive clinical guidance, confirmation bias may guide decision making.
  • Helping Diabetes Patients Exercise Without Fear   Managing blood sugar during and after exercise can be challenging, but clinicians can help patients avoid highs and lows.
  • Type 2 Diabetes in Children Has Researchers Concerned   Reported increases in minority children diagnosed with type 2 diabetes has researchers wondering whether environmental causes and gestational diabetes are to blame.
  • REMOVAL Update: More Benefits of Metformin in T1D   New REMOVAL data presented at EASD 2017 reveal effects of metformin on renal function, biomarkers, and more in patients with type 1 diabetes.
  • Artificial Intelligence May Transform Retinal Screening The new technology is a potential breakthrough for diabetic retinopathy screening, but is not without risks.
  • Halting HF in Patients With Diabetes: Insights From EMPA-REG   A substudy of EMPA-REG finds that SGLT2 inhibitors may slow the onset of heart failure. Dr Piña discusses the research with study investigator Dr Javed Butler at ESC 2017.
  • European Association for the Study of Diabetes (EASD) 2017 Annual Meeting Read clinically focused news coverage of key developments from EASD 2017.